Published in Diabetologia on December 01, 1981
Diabetes, hyperinsulinaemia, and coronary risk factors in Bangladeshis in east London. Br Heart J (1988) 3.05
Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest (1993) 1.75
Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes. Heart Fail Rev (2016) 0.82
Clinical characteristics and beta cell function in Chinese patients with newly diagnosed type 2 diabetes mellitus with different levels of serum triglyceride. BMC Endocr Disord (2015) 0.82
The association between dyslipidemia and anthropometric indicators in black and white adolescents residing in Tlokwe Municipality, North-West Province, South Africa: the PAHL study. Afr Health Sci (2014) 0.76
Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci U S A (1999) 2.16
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. Eur J Clin Pharmacol (1994) 2.04
Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem (1993) 1.57
Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am J Pathol (2001) 1.34
Miniaturization (0.2 g) and evaluation of attachment techniques of telemetry transmitters. J Exp Biol (2005) 1.27
Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J Neurosci (1999) 1.25
Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim Biophys Acta (1995) 1.16
Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations. Biochem J (1994) 1.15
Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. J Lipid Res (1989) 1.09
Asymptomatic bacteriuria in diabetes mellitus. N Engl J Med (1967) 1.05
Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc Natl Acad Sci U S A (1988) 1.00
Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia. Leukemia (2006) 0.99
Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects. Diabetes (1990) 0.96
Characterization of a human high density lipoprotein-associated protein, NA1/NA2. Identity with SP-40,40, an inhibitor of complement-mediated cytolysis. Arterioscler Thromb (1991) 0.94
Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II isolated from human plasma. J Lipid Res (1988) 0.90
[Dyslipidemia in the diabetic patient. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)]. Diabete Metab (1995) 0.85
Treatment of hyperlipoproteinemia (HLP) type II A with a new phenoxy-isobuturic acid derivative, procetofen. Int J Clin Pharmacol Biopharm (1979) 0.85
Peripheral neuropathy associated with high-dose Ara-C therapy. Cancer (1986) 0.83
Lipoprotein (a) and vascular disease in diabetic patients. Diabetologia (1995) 0.83
Linearly polarized light with axial symmetry generated by liquid-crystal polarization converters. Opt Lett (1996) 0.82
Immunoaffinity fractionation of high-density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels. Biochim Biophys Acta (1989) 0.82
Liver glycerokinase deficiency in man with hyperglycerolaemia and hypertriglyceridaemia. Eur J Clin Invest (1984) 0.81
Distribution of apolipoprotein E between free and A-II complexed forms in very-low- and high-density lipoproteins: functional implications. Biochim Biophys Acta (1991) 0.81
HDL particle associated proteins in plasma and cerebrospinal fluid: identification and partial sequencing. Appl Theor Electrophor (1988) 0.81
HDL lipids in close relatives of coronary heart disease patients. Environmental and genetic influences. Atherosclerosis (1979) 0.81
Iron excess, early glucose intolerance and impaired insulin secretion in idiopathic haemochromatosis. Eur J Clin Invest (1973) 0.81
Metabolic effects of dietary fiber from dehulled soybeans in humans. Am J Clin Nutr (1983) 0.80
Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations. Atherosclerosis (1990) 0.80
Noninvasive assessment of the effect of xenobiotics on mitochondrial function in human beings: studies with acetylsalicylic acid and ethanol with the use of the carbon 13-labeled ketoisocaproate breath test. J Lab Clin Med (1995) 0.79
[Apoprotein E (apo E) phenotype and serum lipids in diabetics]. Schweiz Med Wochenschr (1987) 0.79
Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion. Eur J Haematol (2004) 0.79
Phenotyping is an accurate means of analysing the principal apolipoprotein E isoforms. Clin Chim Acta (1994) 0.78
High density lipoprotein cholesterol in male relatives of patients with coronary heart disease. Atherosclerosis (1979) 0.78
Cladribine and severe myelotoxicity. Lancet (1993) 0.78
Apolipoprotein E polymorphism as a risk factor for vascular disease in diabetic patients. Diabetes Care (1995) 0.78
The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1991) 0.78
Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK). Br J Haematol (1997) 0.78
Postprandial lipemia differentially influences high density lipoprotein subpopulations LpAI and LpAI,AII. J Lipid Res (1994) 0.78
Acquired (secondary) forms of hypertriglyceridemia. Am J Cardiol (1991) 0.77
Factors influencing the low density lipoprotein profile in type 2 diabetic patients. Diabet Med (1995) 0.77
HDL and coronary heart disease: a familial trend. Adv Exp Med Biol (1987) 0.77
Apoprotein D in a healthy, male population and in male myocardial infarction patients and their male, first-degree relatives. Atherosclerosis (1986) 0.77
Underexpression of the apolipoprotein E4 isoform in an Italian population. Arterioscler Thromb (1993) 0.77
HDL cholesterol levels in patients with myocardial infarction and their families. Atherosclerosis (1986) 0.76
Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies. Diabetologia (1993) 0.76
Decreased HDL cholesterol in prepubertal and pubertal children of CHD patients. Atherosclerosis (1980) 0.76
Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level. Am J Ophthalmol (1994) 0.75
Marked changes of lipid levels during puberty in a patient with lipoprotein lipase deficiency. Eur J Pediatr (1997) 0.75
Topical timolol maleate might adversely affect serum lipoproteins. Int Ophthalmol (1993) 0.75
Capillary basement membrane thickness in early diabetes. Adv Metab Disord (1973) 0.75
[High-density lipoproteins in children with coronary diseases]. Helv Paediatr Acta (1981) 0.75
[Dyslipidemias and atherosclerosis. Treatment strategy]. Schweiz Rundsch Med Prax (1986) 0.75
The influence of metabolic control on very low density lipoprotein composition in hypertriglyceridemic type II diabetics. A study using heparin-sepharose chromatography. Metabolism (1988) 0.75
Clofibrate, nephrotic syndrome, and histological changes in muscle. Lancet (1973) 0.75
[Hyperlipemia and diabetes]. Schweiz Med Wochenschr (1976) 0.75
Apparent lack of influence of the genetic drug oxidation status on plasma cholesterol concentration in man. Pharmacol Res Commun (1984) 0.75
[Dyslipidemias and diabetes mellitus]. Journ Annu Diabetol Hotel Dieu (1989) 0.75
Preparative isoelectrofocusing and high resolution 2-dimensional gel electrophoresis for concentration and purification of proteins. Appl Theor Electrophor (1991) 0.75
Geneva study on the precursors of atherosclerosis: first results. Soz Praventivmed (1979) 0.75
Lipoprotein complexes in human cerebrospinal fluid. Schweiz Arch Neurol Psychiatr (1993) 0.75
[Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)]. Schweiz Med Wochenschr (1993) 0.75
Evidence for the lipoprotein heterogeneity of human plasma high density lipoproteins isolated by three different procedures. Lipids (1979) 0.75
[HDL-cholesterol and family incidence of coronary disease in the Genevan population]. Schweiz Med Wochenschr (1983) 0.75
Immunological confirmation of the presence of NA1/NA2 (cytolysis inhibitor) in cerebrospinal fluid. Schweiz Arch Neurol Psychiatr (1991) 0.75
[Drug therapy of hyperlipoproteinemias]. Ther Umsch (1980) 0.75
[Coronary insufficiency, hyperlipemia and diabetes]. Journ Annu Diabetol Hotel Dieu (1976) 0.75
High density lipoprotein (HDL) subfractions in cardiovascular patients with low levels of HDL-cholesterol. Influence of hypertriglyceridaemia on subfraction concentration and composition. Atherosclerosis (1988) 0.75
[Low HDL cholesterol in close relatives and patients with myocardial infarct]. Schweiz Med Wochenschr (1978) 0.75
[Procetofen in the treatment of hyperlipoproteinaemias (author's transl)]. Schweiz Rundsch Med Prax (1980) 0.75
[Dietary treatment of the hyperlipidemias]. Ther Umsch (1986) 0.75
Actin stress fiber content of regenerated endothelial cells correlates with intramural retention of intermediate plus low density lipoproteins in rat aorta after balloon injury. Atherosclerosis (1989) 0.75
Lipid, lipoprotein and APO-A and APO-B lipoprotein distribution in Italian and Swiss schoolchildren. The Geneva survey. Pediatr Res (1982) 0.75
[Cholesterol and triglycerides of serum lipoproteins isolated by means of ultracentrifugation. Correlation with arteriosclerosis]. Schweiz Med Wochenschr (1974) 0.75
[Influence of hormonal contraception on serum lipoproteins]. Schweiz Med Wochenschr (1978) 0.75
[Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)]. Nouv Presse Med (1980) 0.75
[Remnant disease associated with apoprotein E1; clinical importance of apoprotein E (apo E) phenotypes]. Schweiz Med Wochenschr (1989) 0.75
A novel high-density lipoprotein particle and associated protein in rat plasma. Biochim Biophys Acta (1990) 0.75
[Coronary atherosclerosis and serum lipoproteins]. Schweiz Med Wochenschr (1979) 0.75
Epitope expression in purified and lipid-bound forms of human apoprotein A-I. Adv Exp Med Biol (1987) 0.75
[Teaching and Treatment Unit in the Division of Diabetology (Geneva)]. Rev Med Suisse Romande (1980) 0.75
[Serum lipoproteins in family members of myocardial infarct victims]. Soz Praventivmed (1978) 0.75
[HDL and lipoproteins in the families of coronary patients]. Schweiz Med Wochenschr (1981) 0.75
[Plasma lipoproteins. Influence of heredity and external factors in the genesis of dyslipidemias]. Rev Med Suisse Romande (1980) 0.75
[Lipoprotein metabolism and atherosclerosis]. Schweiz Rundsch Med Prax (1988) 0.75
[Dyslipidemia in diabetes mellitus: significance, diagnosis and treatment]. Schweiz Rundsch Med Prax (1990) 0.75
[Effect of renal insufficiency on diabetes mellitus]. Rev Med Suisse Romande (1979) 0.75
[Factors influencing the rate of elimination of injected fat emulsions (Intralipid) in healthy subjects and in patients with coronary disease]. Schweiz Med Wochenschr (1976) 0.75
[Dietary lipids and serum lipids in adolescents, based on the Geneva study of the precursors of atherosclerosis]. Soz Praventivmed (1984) 0.75
[Prediabetes and early diabetes]. Pol Tyg Lek (1966) 0.75
Interference of dimethyl alpha-(dimethoxyphosphinyl) p-chlorobenzyl phosphate (SR-202) in thyroid hormone metabolism: evidence of inhibition of monodeiodination. J Endocrinol (1987) 0.75
[Reversible acquired acanthocytosis and hemolytic anemia associated with hypobetalipoproteinemia in a chronic alcoholic]. Schweiz Med Wochenschr (1983) 0.75
[Diet in the treatment of hyperlipidaemia (author's transl)]. Ther Umsch (1980) 0.75
[The clinical importance of cardiovascular risk factors]. Schweiz Rundsch Med Prax (1992) 0.75